Urinalysis Market to Reach US$ 1,779.9 Million by 2027
The rise in the market revenue
for urinalysis is largely due to the increased prevalence of kidney diseases,
UTIs, and other infections. The market will also grow as a result of recent
technological developments in urinalysis. As urinalysis found its greatest
application in UTR diagnosis, urinalysis for urinary tract infections (UTI)
significantly contributes to the market's growth. The potential for urinalysis
was made possible by the rising elderly population.
As a result, end-user
applications like hospitals and clinics, diagnostic laboratories, research
laboratories and institutes, and home care settings are increasingly adopting
urinalysis devices. Additionally, it is used to diagnose a number of metabolic
disorders and to find illnesses like urinary bladder cancer, chronic kidney
disease, and diabetes. The Urinalysis
Market is being supported by new developments like the introduction of
efficient, approachable, and technologically sophisticated tools as well as
growing technical assistance. During the anticipated period, the aforementioned
factors are anticipated to propel the market for urinalysis.
The presence of major market
players like Beckman Coulter Inc. (US) and ACON Labs Inc. as well as growing
geriatric population and increased investment in the development of advanced
urine test products can be attributed to this. An increasing number of people
with chronic lifestyle diseases like diabetes are anticipated to fuel Urinalysis
Market growth in the Asia-Pacific region.
Comments
Post a Comment